Skip to main content
OpenTrials

Clinical trial condition

Pituitary Diseases

Explore clinical trials studying Pituitary Diseases. Study availability and eligibility vary by location and protocol.

673 public trials 95 recruiting studies
Refine in advanced search Browse all conditions

Pituitary Diseases trial results

Completed

"SALT Trial" Study of Ascending Levels of Tolvaptan in Hyponatremia

NCT00072683

Conditions
Brain Diseases, Central Nervous System Diseases, Chemically-Induced Disorders, +23 more
Locations
  • VA Greater Los Angeles Health Care Ctr Los Angeles, California, United States
  • UCLA Los Angeles, California, United States
  • UCSF Medical Center San Francisco, California, United States
  • Aurora Denver Cardiology Association Denver, Colorado, United States
View all 23 locations
View Trial Details
Completed

Safety, PK/PD (Pharmacokinetics/Pharmacodynamics) and Efficacy of ACP-001 Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)

NCT01947907

Conditions
Bone Diseases, Bone Diseases, Developmental, Bone Diseases, Endocrine, +11 more
Locations
  • 2nd Children City Clinic Minsk, Belarus
  • University Multiprofile Hospital for Active Treatment (UMHAT) "Sv. Marina" Varna, Bulgaria
  • Masaryk´s Hospital Ústí nad Labem, Czechia
  • El Shatby University Hospital Alexandria, Egypt
View all 36 locations
View Trial Details
Completed

A Trial to Investigate Long Term Efficacy and Safety of Lonapegsomatropin in Adults With Growth Hormone Deficiency

NCT05171855

Conditions
Adult Growth Hormone Deficiency, Bone Diseases, Bone Diseases, Developmental, +12 more
Locations
  • Ascendis Pharma Investigational Site Phoenix, Arizona, United States
  • Ascendis Pharma Investigational Site Torrance, California, United States
  • Ascendis Pharma Investigational Site Chicago, Illinois, United States
  • Ascendis Pharma Investigational Site Indianapolis, Indiana, United States
View all 85 locations
View Trial Details
Completed

A Trial to Compare the Efficacy and Safety of Once-weekly Lonapegsomatropin With Placebo and a Daily Somatropin Product in Adults With Growth Hormone Deficiency

NCT04615273

Conditions
Bone Diseases, Bone Diseases, Developmental, Bone Diseases, Endocrine, +15 more
Locations
  • Ascendis Pharma Investigational Site Birmingham, Alabama, United States
  • Ascendis Pharma Investigational Site Phoenix, Arizona, United States
  • Ascendis Pharma Investigational Site Fresno, California, United States
  • Ascendis Pharma Investigational Site Los Angeles, California, United States
View all 113 locations
View Trial Details
Completed

Phase 2 Study of LUM-201 in Children With Growth Hormone Deficiency (OraGrowtH210 Trial)

NCT04614337

Conditions
Bone Diseases, Bone Diseases, Developmental, Bone Diseases, Endocrine, +11 more
Locations
  • Center of Excellence in Diabetes and Endocrinology Sacramento, California, United States
  • Rady Children's Hospital San Diego, California, United States
  • Pediatric Endocrine Associates Greenwood Village, Colorado, United States
  • Children's National Hospital Washington D.C., District of Columbia, United States
View all 43 locations
View Trial Details
Completed

Phase 2 Study of LUM-201 in Children Who Have Previously Completed the LUM-201-01 Trial (OraGrowtH213)

NCT05250063

Conditions
Bone Diseases, Bone Diseases, Developmental, Bone Diseases, Endocrine, +11 more
Locations
  • Rady Children's Hospital San Diego, California, United States
  • Children's National Hospital Washington D.C., District of Columbia, United States
  • Indiana University School of Medicine Indianapolis, Indiana, United States
  • M Health, Fairview Pediatric Specialty Clinics- Discovery Clinic Minneapolis, Minnesota, United States
View Trial Details

Related conditions